FDA Adverse Event Injury Summary report: N

CAPIOX FX25 OXYGENATOR

MDR report key: 10307923 · Received July 22, 2020

Report

Report Number
9681834-2020-00137
Event Type
Injury
Date Received
July 22, 2020
Date of Event
June 4, 2020
Report Date
July 22, 2020
Manufacturer
TERUMO CORPORATION, ASHITAKA
Product Code
DTZ
PMA / PMN Number
K071494
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
FR
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

IMPLANTED DATE: DEVICE WAS NOT IMPLANTED. EXPLANTED DATE: DEVICE WAS NOT EXPLANTED. PMA/510(K) - K130280. THE ACTUAL DEVICE WAS NOT RETURNED; THEREFORE, AN EVALUATION OF THE ACTUAL DEVICE WAS UNABLE TO BE CONDUCTED. A REVIEW OF THE DEVICE HISTORY RECORD AND PRODUCT RELEASE DECISION CONTROL SHEET OF THE INVOLVED PRODUCT CODE/LOT# COMBINATION WAS CONDUCTED WITH NO FINDINGS. REVIEW OF THE SHIPPING INSPECTION RECORD OF THE INVOLVED FIBER LOT CONFIRMED THAT THE GAS TRANSFER PERFORMANCE TEST AND PRESSURE DROP TEST RESULTS MET THE MANUFACTURER CONTROL CRITERIA AND NO ANOMALY WAS NOTED. IT IS LIKELY THAT POST-OPERATIVE HEMATURIA URINE APPEARED BECAUSE HEMOLYSIS MIGHT HAVE OCCURRED DUE TO SOME FACTORS. HOWEVER, WITH NO RETURN OF THE ACTUAL DEVICE, THE EXACT CAUSE OF THE REPORTED EVENT CANNOT BE DEFINITIVELY DETERMINED BASED ON THE AVAILABLE INFORMATION. (B)(4).

Description of Event or Problem · 1

THE USER FACILITY REPORTED THAT THE INVOLVED CAPIOX DEVICE WAS USED DURING THE PROCEDURE. POST-OPERATIVE HEMATURIA URINE WAS FOUND WHEN THE PATIENT WAS TRANSFERRED FROM THE OPERATING TABLE TO HIS BED. DURING THE BYPASS THE URINE IS SMALL; HOWEVER, CLEAR. THE BYPASS LASTED 2 HOURS AND 28 MINUTES WITHOUT ANY PARTICULAR CONCERN EXCEPT FOR SOME UNEXPLAINED HEMODYNAMIC PROBLEMS (VARIATION OF BLOOD PRESSURE) TRANSMITTED TO THE ANESTHETIST. PROBABLE HEMOLYSIS. THE PATIENT IMPACT AND PROCEDURE OUTCOME WERE NOT REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
771259 CAPIOX FX25 OXYGENATOR OXYGENATOR, CARDIOPULMONARY BYPASS DTZ TERUMO CORPORATION, ASHITAKA NA 190705

Patients

Seq Age Sex Outcome Treatment
1 Other